Efficacy of Immune Checkpoint Inhibitors in Metastatic Melanoma (MM) Patients with Concurrent Chronic Lymphocytic Leukemia (CLL)

被引：0
|
作者：
Guerra, Veronica [1 ]
Ologun, Gabriel [2 ]
Haydu, Lauren [2 ]
Keung, Emily [2 ]
Burton, Elizabeth [2 ]
Tawbi, Hussein [3 ]
Davis, Michael [3 ]
Wargo, Jennifer [2 ]
Ferrajoli, Alessandra [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2020年 / 20卷
关键词：
chronic lymphocytic leukemia; CLL; melanoma; immune checkpoint inhibitors; nivolumab; ipilimumab; pembrolizumab;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CLL-229
引用
收藏
页码：S225 / S225
页数：1
相关论文
共 50 条
  • [41] Management of melanoma in patients with chronic lymphocytic leukemia
    Archibald, William J.
    Meacham, Philip J.
    Williams, AnnaLynn M.
    Baran, Andrea M.
    Victor, Adrienne, I
    Barr, Paul M.
    Sahasrahbudhe, Deepak M.
    Zent, Clive S.
    LEUKEMIA RESEARCH, 2018, 71 : 43 - 46
  • [42] Safety of Immune Checkpoint Inhibitors in Patients With Advanced Chronic Kidney Disease: A Retrospective Cohort Study
    Tiu, Bruce C.
    Strohbehn, Ian A.
    Zhao, Sophia
    Ouyang, Tianqi
    Hanna, Paul
    Wang, Qiyu
    Gupta, Shruti
    Leaf, David E.
    Reynolds, Kerry L.
    Sise, Meghan E.
    ONCOLOGIST, 2023, 28 (06) : E379 - E390
  • [43] Efficacy of immune checkpoint inhibitors in patients with anorectal melanoma in association with immune-related adverse events: a case series
    Reiko Yokoyama
    Yasushi Sato
    Fumika Nakamura
    Kaizo Kagemoto
    Yasuhiro Mitsui
    Koichi Okamoto
    Yutaka Kawano
    Masahiro Sogabe
    Hiroshi Miyamoto
    Tetsuji Takayama
    Clinical Journal of Gastroenterology, 2023, 16 (6) : 842 - 847
  • [44] An enhanced genetic mutation-based model for predicting the efficacy of immune checkpoint inhibitors in patients with melanoma
    Pan, Chaohu
    Tang, Hongzhen
    Wang, Wei
    Wu, Dongfang
    Luo, Haitao
    Xu, Libin
    Lin, Xue-Jia
    FRONTIERS IN ONCOLOGY, 2023, 12
  • [45] The impact of immunosenescence on the efficacy of immune checkpoint inhibitors in melanoma patients: a meta-analysis
    Li, Ping
    Yang, Xuefang
    Feng, Yumiao
    Wu, Lijuan
    Ma, Wei
    Ding, Gaozhong
    Wei, Yun
    Sun, Lan
    ONCOTARGETS AND THERAPY, 2018, 11 : 7521 - 7527
  • [46] Immune checkpoint inhibitors and targeted therapies for metastatic melanoma: A network meta-analysis
    Pasquali, Sandro
    Chiarion-Sileni, Vanna
    Rossi, Carlo Riccardo
    Mocellin, Simone
    CANCER TREATMENT REVIEWS, 2017, 54 : 34 - 42
  • [47] Systematic evaluation of the predictive gene expression signatures of immune checkpoint inhibitors in metastatic melanoma
    Coleman, Samuel
    Xie, Mengyu
    Tarhini, Ahmad A.
    Tan, Aik Choon
    MOLECULAR CARCINOGENESIS, 2023, 62 (01) : 77 - 89
  • [48] Expression of DNA mismatch repair proteins in melanoma patients treated with immune checkpoint inhibitors
    Gambichler, T.
    Finis, C.
    Abu Rached, N.
    Scheel, C. H.
    Becker, J. C.
    Lang, K.
    Kafferlein, H. U.
    Bruning, T.
    Abolmaali, N.
    Susok, L.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (03) : 1241 - 1247
  • [49] Immune checkpoint inhibitors in advanced or metastatic mucosal melanoma: a systematic review
    Li, Jiarui
    Kan, Haoxuan
    Zhao, Lin
    Sun, Zhao
    Bai, Chunmei
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [50] Expression of DNA mismatch repair proteins in melanoma patients treated with immune checkpoint inhibitors
    T. Gambichler
    C. Finis
    N. Abu Rached
    C. H. Scheel
    J. C. Becker
    K. Lang
    H. U. Käfferlein
    T. Brüning
    N. Abolmaali
    L. Susok
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 1241 - 1247
12345